Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Verbist

Showing results (571-580 of 588) with videos related to

Pageof 59
Sort By:
Blood Advances|July 31, 2023
ETV6 represses inflammatory response genes and regulates HSPC function during stress hematopoiesis in miceMackenzie Bloom, Ninad Oak, Rebekah Baskin-Doerfler, et al.
European Journal of Radiology|July 19, 2018
The interobserver agreement in the detection of recurrent HNSCC using MRI including diffusion weighted MRIBoris Peltenburg, Juliette P Driessen, Marielle E P Philippens, et al.
Plos Genetics|October 7, 2025
Immunophenotypic changes in the tumor and tumor microenvironment during progression to multiple myelomaIsabelle Bergiers, Murat Cem Köse, Sheri Skerget, et al.
BMJ Open|April 8, 2026
[<sup>89</sup>Zr]bevacizumab PET/CT imaging of vestibular schwannomas for the prediction of bevacizumab treatment effect in patients with symptomatic <i>NF2</i>-related schwannomatosis: a study protocol for a phase II single centre, prospective, feasibility trialJules P J Douwes, Annemijn L Tops, Petra Dibbets-Schneider, et al.
Cell Host & Microbe|June 21, 2016
RIPK3 Activates Parallel Pathways of MLKL-Driven Necroptosis and FADD-Mediated Apoptosis to Protect against Influenza A VirusShoko Nogusa, Roshan J Thapa, Christopher P Dillon, et al.
The Lancet. Gastroenterology & Hepatology|May 1, 2018
Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing studyEleanor Fewings, Alexey Larionov, James Redman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2017
Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group InitiativeTine Cuppens, Daniela Annibali, An Coosemans, et al.
Blood|July 22, 2020
Molecular basis of ETV6-mediated predisposition to childhood acute lymphoblastic leukemiaRina Nishii, Rebekah Baskin-Doerfler, Wentao Yang, et al.
Human Genetics|May 14, 2018
Heterozygous missense variants of LMX1A lead to nonsyndromic hearing impairment and vestibular dysfunctionMieke Wesdorp, Pia A M de Koning Gans, Margit Schraders, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 6, 2018
Variants affecting diverse domains of MEPE are associated with two distinct bone disorders, a craniofacial bone defect and otosclerosisIsabelle Schrauwen, Hanne Valgaeren, Laura Tomas-Roca, et al.
Pageof 59

Showing results (571-580 of 588) with videos related to

Sort By:
Pageof 59
Blood Advances|July 31, 2023
ETV6 represses inflammatory response genes and regulates HSPC function during stress hematopoiesis in miceMackenzie Bloom, Ninad Oak, Rebekah Baskin-Doerfler, et al.
European Journal of Radiology|July 19, 2018
The interobserver agreement in the detection of recurrent HNSCC using MRI including diffusion weighted MRIBoris Peltenburg, Juliette P Driessen, Marielle E P Philippens, et al.
Plos Genetics|October 7, 2025
Immunophenotypic changes in the tumor and tumor microenvironment during progression to multiple myelomaIsabelle Bergiers, Murat Cem Köse, Sheri Skerget, et al.
BMJ Open|April 8, 2026
[<sup>89</sup>Zr]bevacizumab PET/CT imaging of vestibular schwannomas for the prediction of bevacizumab treatment effect in patients with symptomatic <i>NF2</i>-related schwannomatosis: a study protocol for a phase II single centre, prospective, feasibility trialJules P J Douwes, Annemijn L Tops, Petra Dibbets-Schneider, et al.
Cell Host & Microbe|June 21, 2016
RIPK3 Activates Parallel Pathways of MLKL-Driven Necroptosis and FADD-Mediated Apoptosis to Protect against Influenza A VirusShoko Nogusa, Roshan J Thapa, Christopher P Dillon, et al.
The Lancet. Gastroenterology & Hepatology|May 1, 2018
Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing studyEleanor Fewings, Alexey Larionov, James Redman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2017
Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group InitiativeTine Cuppens, Daniela Annibali, An Coosemans, et al.
Blood|July 22, 2020
Molecular basis of ETV6-mediated predisposition to childhood acute lymphoblastic leukemiaRina Nishii, Rebekah Baskin-Doerfler, Wentao Yang, et al.
Human Genetics|May 14, 2018
Heterozygous missense variants of LMX1A lead to nonsyndromic hearing impairment and vestibular dysfunctionMieke Wesdorp, Pia A M de Koning Gans, Margit Schraders, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 6, 2018
Variants affecting diverse domains of MEPE are associated with two distinct bone disorders, a craniofacial bone defect and otosclerosisIsabelle Schrauwen, Hanne Valgaeren, Laura Tomas-Roca, et al.
Pageof 59